Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

PRLR (prolactin receptor)

Written2004-10Chon-Hwa Tsai-Morris, Maria L Dufau
Section on Molecular Endocrinology, Program Developmental Endocrinology, Genetics, NICHD, National Institutes of Health, Bethesda, MD 20892-4510, USA
Updated2011-12Chon-Hwa Tsai-Morris, Maria L Dufau
Section on Molecular Endocrinology, Program Developmental Endocrinology, Genetics, NICHD, National Institutes of Health, Bethesda, MD 20892-4510, USA

(Note : for Links provided by Atlas : click)

Identity

Other aliasPRL-R
HGNC (Hugo) PRLR
LocusID (NCBI) 5618
Atlas_Id 42891
Location 5p13.2  [Link to chromosome band 5p13]
Location_base_pair Starts at 35055697 and ends at 35230589 bp from pter ( according to hg19-Feb_2009)  [Mapping PRLR.png]
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
CEP44 (4q34.1) / PRLR (5p13.2)PRLR (5p13.2) / KDM3B (5q31.2)PRLR (5p13.2) / PLCXD3 (5p13.1)
PRLR (5p13.2) / PRLR (5p13.2)PRLR (5p13.2) / RHOG (11p15.4)
Note The PRLR belongs to the class I cytokine receptor family. This receptor binds the pituitary hormone prolactin with high affinity. It contains an extracellular binding domain with 2 fibronectin-like type III domains, a single transmembrane domain, and an intracellular domain required for signal transduction (via JAK-2/STAT5 and other pathways) that lacks intrinsic kinase activity.

DNA/RNA

 
  Figure 1. A. Localization of multiple first exons and exons 2-11 of the human prolactin receptor gene in chromosome 5p 14-13. Alternative exons 1: hE13 (generic) and hE1N1-5 (human specific); exon 2: non-coding exon; exon 3: non-coding/coding ATG translation initiation codon; exons 4-11: coding exons. B. Schematic representation of multiple exons 1 and alternative splicing to common exon 2. C. Model for E2-ERα-Sp1-C/EBPβ formation and binding to the hPIII promoter of the human prolactin receptor gene. Schematic presentation of the functional domain of ERα, Sp1 and C/EBPβ and the cognate DNA binding site of Sp1 and C/EBPβ in the hPIII promoter. Each protein is constitutively present as a homodimer dimer. ERα:AF: transactivation domain, DBD: DNA binding domain, H: hinge region, LBD: ligand binding domain; C/EBPβ:BR: basic region, LZ: leucine zipper domain; Sp1:TAD: transactivation domain, ZF: zinc finger motif.
Description The genomic size of human PRLR gene exceeds 200 kb and contains 11 exons, including six non-coding exons 1 alternative spliced to a common non-coding exon 2 and exon 3-10 that encode the full length activating long form of the receptor. Intermediate and various short forms resulting from alternative splicing. Sequences from exon 11 are present only in the short forms of the receptor S1a and S1b and their respective variants.
Transcription Transcription of human prolactin receptor gene is regulated by a multiple and tissue-specific promoter (hPIII for exons 1 species hE13 and hPN1-5 for exons 1 species hE1N1-5). The prolactin receptor promoters belong to the TATA-less/non-initiator class. The hPIII promoter contains Sp1 and C/EBP elements that bind Sp1/Sp3 and C/EBPβ required for basal and regulated transcriptional activity, while hPN1 activity is conferred by domains containing an Ets element and an NR half-site. hPN2-5 have not been characterized. Estrogen regulates PRLR transcription through the preferentially utilized PIII promoter via a non-classical ERE independent mechanism in target cells. The protein association induced by estradiol of estrogen receptor α (ERα) with DNA-bound Sp1 (constitutive) and C/EBPβ (recruited by the ERα-SP1 complex) is essential for human prolaction receptor gene transcription (figure 1C). Additional interaction between zinc fingers of Sp1 and leucine zipper of C/EBPβ stabilizes the ERα-Sp1-C/EBPβ complex. The enhanced complex formation of ERα dimer (DNA binding domain) with Sp1 (zinc finger motifs) and C/EBPβ (basic region and leucine zipper) by E2 plays an essential role in the transcriptional activation of the hPRLR gene.
Pseudogene No known pseudogenes.

Protein

 
  Figure 2. A. Schematic representation of human PRLR variants. Forms generated by alternative splicing. B. Structure of human prolactin receptor variants. Receptor structure of the various forms. LF: long form; IF: intermediate form; S: short forms; 10': partial exon 10; Δ#: deleted exon; #/#: exon/exon splice variant; D1, D2: N-terminal subdomain; WS: WSXWS motif; C: cysteine; Y: tyrosine; EC: extracellular domain; TM: transmembrane domain; IC: intracellular domain. Blue boxes (dark and light) in IC represent two unique sequences of short forms derived from exon 11. Amino acid number includes the signal peptide.
Description Several forms of the human prolactin receptor have been identified including the full length activating receptor (LF) and at least eight other variants (figures 2A and 2B). These variants differ by the length and composition of their extracellular and/or cytoplasmic domain. In addition to the membrane anchored prolactin receptors variants there is a soluble isoform (prolactin receptor binding protein -PRLRBP) that is generated by proteolytic cleavage of membrane bound prolactin receptor. The human prolactin receptor is composed of a single transmembrane domain, a ligand binding extracellular domain and a cytoplasmic domain which is required for signal transduction. Two disulfide-linked cysteines in the D1 subdomain are involved in ligand binding while WSXWS motif in the D2 subdomain is probably required for correct folding and cellular trafficking. Box 1, a proline rich domain highly conserved in the cytokine receptor family, is the JAK2 docking site. The activated JAK2 induced by prolactin (autophosphorylation), phosphorylates the dimerized receptor preferentially Y587 (at a consensus tyrosine phosphorylation site) which is only present in LF and ΔS1 (figure 2A). This is followed by phosphorylation, dimerization and nuclear translocation of STAT5 which causes transcriptional activation of prolactin responsive genes (i.e. β-casein, β-lactoglobulin, whey acidic protein, interferon-regulatory factor 1 and others). There are other nine tyrosines in the cytoplasmic domain (non-consensus phosphorylation sites) some of which may undergo phosphorylation and may participate in signal transduction. Box2 of unknown function is less conserved in the cytokine receptor family. Prolactin can also activate other tyrosine kinases, including Src family kinases, focal adhesion proteins, Tec kinase, and ErbB kinase. Prolactin induces the GRB2/SOS/Ras/Raf/MAPK signaling cascade. Prolactin through the long form of the receptor stimulates cell proliferation. The Δ-S1 form lacking exon 4 and 5, has reduced affinity for the hormone (due to abbreviated extracellular domain) but displays effective signal transduction. Stimulation of the intermediate form of the receptor (major deletion of exon 10, cytoplasmic domain) only with high concentrations of the ligand exhibits minor cell proliferation. The short forms of the receptor S1a and S1b derived from alternative splicing of exons 10 and 11 are inhibitory of the activation induced by prolactin through the long form of the receptor (see above). Intramolecular disulfide bonds of the prolactin receptor short form are required from its inhibitory action on the function of the long form of the receptor. Δ7/11 and Δ4-Δ7/11 isoforms do not contain transmembrane domain. Δ7/11, Δ4-Δ7/11 and PRLBP are soluble prolactin receptor. Δ4/6 S1a (Acc#. AF512796) variant encodes two open reading frames either 245 or 49 aa truncated prolactin receptor. Spliced variant S1c missing exon 10 was identified in spermatozoa (Acc#. GU133399).
Expression Prolactin receptors have been identified in number of cells and tissues including the mammary gland, organs of the reproductive system, central nervous system, pituitary, adrenal cortex, skin, bone, lung, heart, liver, pancreas, GI tract, kidney, lymphoid tissue and spermatozoa. These are also present in breast cancer tissues and cells and in other tumoral tissues/cells.
Localisation Localized in the cell membrane, but also present intracellularly at various compartments.
Function The prolactin receptor mediates prolactin signaling and triggers intracellular responses that participate in diverse biological functions including, mammary gland development (proliferation and differentiation), initiation and maintenance of lactation, regulation of water and salt balance, reproduction, gonadal steroidogenesis, preservation of sperm integrity, embryonic implantation, brain and behavior, and immune-regulation (see description).

Implicated in

Note
  
Entity Various diseases
Note Changes in the expression of prolactin receptor variants were found in breast cancer tissues and cells lines when compared to adjacent normal tissues/cells. Polymorphism of prolactin receptor may be related to breast carcinoma, multiple sclerosis and systemic lupus erythematosus. Two missense variants found in patients with breast tumor, Valine for Isoleucine 76 (I76V) and Leucine for Isoleucine 146 (I146L) with gain of function were proposed to participate in breast tumorigenesis.
  

Bibliography

Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, Bachelot A, Kuttenn F, Kelly PA, Goffin V, Touraine P; Benign Breast Diseases Study Group.
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14533-8. Epub 2008 Sep 8.
PMID 18779591
 
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells.
Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, Gould D, Djiane J, Kelly PA.
Mol Endocrinol. 1989 Sep;3(9):1455-61.
PMID 2558309
 
Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
Canbay E, Degerli N, Gulluoglu BM, Kaya H, Sen M, Bardakci F.
Curr Med Res Opin. 2004 Apr;20(4):533-40.
PMID 15119991
 
Presence and characterization of prolactin receptors in human benign breast tumours.
Di Carlo R, Muccioli G, Bellussi G, Lando D, Mussa A.
Eur J Cancer Clin Oncol. 1984 May;20(5):635-8.
PMID 6145592
 
A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
Dong J, Tsai-Morris CH, Dufau ML.
J Biol Chem. 2006 Jul 7;281(27):18825-36. Epub 2006 May 1.
PMID 16651265
 
Absence of prolactin receptors in normal and malignant uterine cervix.
Dowsett M, McGarrick GE, Staffurth J, Worth RW, Chapman MG, Jeffcoate SL.
Br J Obstet Gynaecol. 1984 Sep;91(9):924-6.
PMID 6089861
 
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.
Gill S, Peston D, Vonderhaar BK, Shousha S.
J Clin Pathol. 2001 Dec;54(12):956-60.
PMID 11729217
 
Identification of gain-of-function variants of the human prolactin receptor.
Goffin V, Bogorad RL, Touraine P.
Methods Enzymol. 2010;484:329-55.
PMID 21036240
 
Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11.
Hu ZZ, Meng J, Dufau ML.
J Biol Chem. 2001 Nov 2;276(44):41086-94. Epub 2001 Aug 22.
PMID 11518703
 
Complex 5' genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization.
Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH, Dufau ML.
Endocrinology. 2002 Jun;143(6):2139-42.
PMID 12021177
 
Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription.
Kang JH, Tsai-Morris CH, Dufau ML.
Mol Cell Biol. 2011 Aug;31(16):3208-22. Epub 2011 Jun 13.
PMID 21670145
 
Functional characterization of the intermediate isoform of the human prolactin receptor.
Kline JB, Roehrs H, Clevenger CV.
J Biol Chem. 1999 Dec 10;274(50):35461-8.
PMID 10585417
 
Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
Kline JB, Rycyzyn MA, Clevenger CV.
Mol Endocrinol. 2002 Oct;16(10):2310-22.
PMID 12351696
 
Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues.
Laud K, Gourdou I, Belair L, Peyrat JP, Djiane J.
Int J Cancer. 2000 Mar 15;85(6):771-6.
PMID 10709093
 
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.
Mellai M, Giordano M, D'Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, Leone M, Ferro I, Liguori M, Trojano M, Ballerini C, Massacesi L, Cannoni S, Bomprezzi R, Momigliano-Richiardi P.
Hum Immunol. 2003 Feb;64(2):274-84.
PMID 12559630
 
Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma.
Meng J, Tsai-Morris CH, Dufau ML.
Cancer Res. 2004 Aug 15;64(16):5677-82.
PMID 15313907
 
Prolactin exerts a prosurvival effect on human spermatozoa via mechanisms that involve the stimulation of Akt phosphorylation and suppression of caspase activation and capacitation.
Pujianto DA, Curry BJ, Aitken RJ.
Endocrinology. 2010 Mar;151(3):1269-79. Epub 2009 Dec 23.
PMID 20032052
 
Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.
Qazi AM, Tsai-Morris CH, Dufau ML.
Mol Endocrinol. 2006 Aug;20(8):1912-23. Epub 2006 Mar 23.
PMID 16556730
 
Short form 1b human prolactin receptor down-regulates expression of the long form.
Tan D, Walker AM.
J Mol Endocrinol. 2010 Mar;44(3):187-94. Epub 2009 Nov 11.
PMID 19906835
 
Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein.
Trott JF, Hovey RC, Koduri S, Vonderhaar BK.
J Mol Endocrinol. 2003 Feb;30(1):31-47.
PMID 12580759
 
Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.
Xie YL, Hassan SA, Qazi AM, Tsai-Morris CH, Dufau ML.
Mol Cell Biol. 2009 May;29(10):2546-55. Epub 2009 Mar 9.
PMID 19273600
 

Citation

This paper should be referenced as such :
Tsai-Morris, CH ; Dufau, ML
PRLR (prolactin receptor)
Atlas Genet Cytogenet Oncol Haematol. 2012;16(5):361-365.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Genes/PRLRID42891ch5p14.html
History of this paper:
Tsai-Morris, CH ; Dufau, ML. PRLR (prolactin receptor). Atlas Genet Cytogenet Oncol Haematol. 2004;8(4):314-317.
http://documents.irevues.inist.fr/bitstream/handle/2042/38132/10-2004-PRLRID42891ch5p14.pdf


Other Leukemias implicated (Data extracted from papers in the Atlas) [ 1 ]
  del(9p) in Acute Lymphoblastic Leukemia


External links

Nomenclature
HGNC (Hugo)PRLR   9446
Cards
AtlasPRLRID42891ch5p14
Entrez_Gene (NCBI)PRLR  5618  prolactin receptor
AliasesHPRL; MFAB; hPRLrI
GeneCards (Weizmann)PRLR
Ensembl hg19 (Hinxton)ENSG00000113494 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000113494 [Gene_View]  chr5:35055697-35230589 [Contig_View]  PRLR [Vega]
ICGC DataPortalENSG00000113494
TCGA cBioPortalPRLR
AceView (NCBI)PRLR
Genatlas (Paris)PRLR
WikiGenes5618
SOURCE (Princeton)PRLR
Genetics Home Reference (NIH)PRLR
Genomic and cartography
GoldenPath hg38 (UCSC)PRLR  -     chr5:35055697-35230589 -  5p13.2   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)PRLR  -     5p13.2   [Description]    (hg19-Feb_2009)
EnsemblPRLR - 5p13.2 [CytoView hg19]  PRLR - 5p13.2 [CytoView hg38]
Mapping of homologs : NCBIPRLR [Mapview hg19]  PRLR [Mapview hg38]
OMIM176761   615554   615555   
Gene and transcription
Genbank (Entrez)###############################################################################################################################################################################################################################################################
RefSeq transcript (Entrez)NM_000949 NM_001204314 NM_001204315 NM_001204316 NM_001204317 NM_001204318
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)PRLR
Cluster EST : UnigeneHs.602914 [ NCBI ]
CGAP (NCI)Hs.602914
Alternative Splicing GalleryENSG00000113494
Gene ExpressionPRLR [ NCBI-GEO ]   PRLR [ EBI - ARRAY_EXPRESS ]   PRLR [ SEEK ]   PRLR [ MEM ]
Gene Expression Viewer (FireBrowse)PRLR [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevestigatorExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)5618
GTEX Portal (Tissue expression)PRLR
Human Protein AtlasENSG00000113494-PRLR [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtP16471   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtP16471  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProP16471
Splice isoforms : SwissVarP16471
PhosPhoSitePlusP16471
Domaine pattern : Prosite (Expaxy)FN3 (PS50853)    HEMATOPO_REC_L_F1 (PS01352)   
Domains : Interpro (EBI)FN3_dom    Growth/epo_recpt_lig-bind    Ig-like_fold    Long_hematopoietin_rcpt_CS    PRLR   
Domain families : Pfam (Sanger)EpoR_lig-bind (PF09067)   
Domain families : Pfam (NCBI)pfam09067   
Domain families : Smart (EMBL)FN3 (SM00060)  
Conserved Domain (NCBI)PRLR
DMDM Disease mutations5618
Blocks (Seattle)PRLR
PDB (SRS)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
PDB (PDBSum)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
PDB (IMB)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
PDB (RSDB)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
Structural Biology KnowledgeBase1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
SCOP (Structural Classification of Proteins)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
CATH (Classification of proteins structures)1BP3    2LFG    2N7I    3D48    3MZG    3N06    3N0P    3NCB    3NCC    3NCE    3NCF    4I18   
SuperfamilyP16471
Human Protein Atlas [tissue]ENSG00000113494-PRLR [tissue]
Peptide AtlasP16471
HPRD01457
IPIIPI00028640   IPI00219095   IPI00152476   IPI00044214   IPI00163730   IPI00852725   IPI00853288   IPI00954795   IPI01010674   IPI00967903   IPI00968148   IPI00964477   IPI00965170   IPI00967502   IPI00969101   IPI00965938   
Protein Interaction databases
DIP (DOE-UCLA)P16471
IntAct (EBI)P16471
FunCoupENSG00000113494
BioGRIDPRLR
STRING (EMBL)PRLR
ZODIACPRLR
Ontologies - Pathways
QuickGOP16471
Ontology : AmiGOprolactin receptor activity  protein binding  extracellular region  plasma membrane  steroid biosynthetic process  cell surface receptor signaling pathway  activation of transmembrane receptor protein tyrosine kinase activity  embryo implantation  lactation  cell surface  integral component of membrane  peptide hormone binding  endosome lumen  prolactin signaling pathway  T cell activation  protein homodimerization activity  ornithine decarboxylase activator activity  negative regulation of apoptotic process  metal ion binding  JAK-STAT cascade involved in growth hormone signaling pathway  
Ontology : EGO-EBIprolactin receptor activity  protein binding  extracellular region  plasma membrane  steroid biosynthetic process  cell surface receptor signaling pathway  activation of transmembrane receptor protein tyrosine kinase activity  embryo implantation  lactation  cell surface  integral component of membrane  peptide hormone binding  endosome lumen  prolactin signaling pathway  T cell activation  protein homodimerization activity  ornithine decarboxylase activator activity  negative regulation of apoptotic process  metal ion binding  JAK-STAT cascade involved in growth hormone signaling pathway  
Pathways : KEGGCytokine-cytokine receptor interaction    Neuroactive ligand-receptor interaction    PI3K-Akt signaling pathway    Jak-STAT signaling pathway    Prolactin signaling pathway   
REACTOMEP16471 [protein]
REACTOME PathwaysR-HSA-982772 [pathway]   
NDEx NetworkPRLR
Atlas of Cancer Signalling NetworkPRLR
Wikipedia pathwaysPRLR
Orthology - Evolution
OrthoDB5618
GeneTree (enSembl)ENSG00000113494
Phylogenetic Trees/Animal Genes : TreeFamPRLR
HOVERGENP16471
HOGENOMP16471
Homologs : HomoloGenePRLR
Homology/Alignments : Family Browser (UCSC)PRLR
Gene fusions - Rearrangements
Fusion : MitelmanPRLR/KDM3B [5p13.2/5q31.2]  
Fusion : MitelmanPRLR/PLCXD3 [5p13.2/5p13.1]  [t(5;5)(p13;p13)]  
Fusion: TCGA_MDACCPRLR 5p13.2 KDM3B 5q31.2 BRCA
Fusion: TCGA_MDACCPRLR 5p13.2 PLCXD3 5p13.1 BRCA
Tumor Fusion PortalPRLR
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerPRLR [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)PRLR
dbVarPRLR
ClinVarPRLR
1000_GenomesPRLR 
Exome Variant ServerPRLR
ExAC (Exome Aggregation Consortium)ENSG00000113494
GNOMAD BrowserENSG00000113494
Genetic variants : HAPMAP5618
Genomic Variants (DGV)PRLR [DGVbeta]
DECIPHERPRLR [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisPRLR 
Mutations
ICGC Data PortalPRLR 
TCGA Data PortalPRLR 
Broad Tumor PortalPRLR
OASIS PortalPRLR [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICPRLR  [overview]  [genome browser]  [tissue]  [distribution]  
Mutations and Diseases : HGMDPRLR
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch PRLR
DgiDB (Drug Gene Interaction Database)PRLR
DoCM (Curated mutations)PRLR (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)PRLR (select a term)
intoGenPRLR
NCG5 (London)PRLR
Cancer3DPRLR(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM176761    615554    615555   
Orphanet22691    10661   
DisGeNETPRLR
MedgenPRLR
Genetic Testing Registry PRLR
NextProtP16471 [Medical]
TSGene5618
GENETestsPRLR
Target ValidationPRLR
Huge Navigator PRLR [HugePedia]
snp3D : Map Gene to Disease5618
BioCentury BCIQPRLR
ClinGenPRLR
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD5618
Chemical/Pharm GKB GenePA33791
Clinical trialPRLR
Miscellaneous
canSAR (ICR)PRLR (select the gene name)
Probes
Litterature
PubMed144 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMinePRLR
EVEXPRLR
GoPubMedPRLR
iHOPPRLR
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Nov 21 15:00:10 CET 2017

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.